What a year of semaglutide actually costs
Every price you see is monthly. Every course of treatment is annual. The gap between those two numbers is where the real cost hides.
Over a full year in 2026, semaglutide costs range from roughly $1,200 for the lowest compounded injectable programs to $6,000+ for brand injectable Wegovy at self-pay retail. The Wegovy pill lands around $2,900–$3,200 after titration; compounded sublingual ODT programs run $1,980–$2,388. Annual totals diverge from advertised monthly prices because of titration, mandatory fees, plan commitments, and the difference between starter and maintenance pricing.
- Why the monthly number misleads: Semaglutide is a long-term therapy.
- Brand semaglutide across a year: Injectable Wegovy at self-pay retail runs several hundred dollars a month; through NovoCare's cash-pay channel the figure is lower but still lands a y.
- Compounded injectable across a year: Legitimate compounded injectable semaglutide programs, where lawfully available, cluster around $100–$200 per month all-inclusive, putting a year near.
- Sublingual ODT across a year: Compounded sublingual semaglutide ODT programs are priced separately and should be evaluated separately, because — as our ODT evidence guide details —.
- The fees that inflate the real total: Beyond the medication, annual totals swell from fees that monthly ads omit: mandatory membership charges, required lab work, clinician consultation fe.
Why the monthly number misleads
Semaglutide is a long-term therapy. Weight-management trials run 64 to 68 weeks, and discontinuation studies show substantial weight regain after stopping — so the honest planning horizon is a year or more, not a month. Yet every program advertises a monthly price, and often the lowest monthly price on offer: the starter dose, the first month, or the 12-month prepaid rate.
The result is a systematic understatement. A program advertising “from $99” may bill $99 only at the starting dose, only on a 12-month commitment, or only for the first shipment. The annual total — what you will actually pay across twelve months of real treatment — is the number that lets you compare programs honestly, and it is almost never the one on the landing page.
| Route | Monthly range | Annual estimate | FDA approved |
|---|---|---|---|
| Compounded injectable (where lawful) | $100–$200 | $1,200–$2,400 | No |
| Sublingual ODT (unproven) | $165–$199 | $1,980–$2,388 | No |
| Wegovy pill (titrated) | $149–$299 | $2,900–$3,200 | Yes |
| Brand injectable Wegovy (self-pay) | ~$350–$500 | $4,000–$6,000 | Yes |
| Insured (weight-loss covered) | ~$25 copay | ~$300 | Yes |
Brand semaglutide across a year
Injectable Wegovy at self-pay retail runs several hundred dollars a month; through NovoCare's cash-pay channel the figure is lower but still lands a year in the multiple-thousands. Across twelve months at maintenance, brand injectable Wegovy self-pay sits in the roughly $4,000–$6,000 range depending on channel and any savings offer, before clinic or lab fees.
The Wegovy pill changes the brand math. At $149 for starter doses and about $299 for the 9 and 25 mg maintenance doses, a titrated year lands roughly $2,900–$3,200 self-pay — the cheapest FDA-approved route to semaglutide for a cash-pay weight-loss patient without insurance. Insured copays, where a plan covers weight-loss GLP-1s, can drop any of these to a few hundred dollars for the year.
Compounded injectable across a year
Legitimate compounded injectable semaglutide programs, where lawfully available, cluster around $100–$200 per month all-inclusive, putting a year near $1,200–$2,400. That is the floor of the semaglutide market and the reason the compounded route grew — though, as our compounding-rules guide explains, the post-shortage legal constraints now limit who can lawfully provide it and on what basis.
The annual-cost caveat still applies: check whether that monthly rate requires a 12-month prepaid commitment, whether shipping and clinician fees are included, and whether the price holds at every dose. Flat-priced programs that don't charge more as you titrate produce a predictable annual total; dose-priced programs do not.
Sublingual ODT across a year
Compounded sublingual semaglutide ODT programs are priced separately and should be evaluated separately, because — as our ODT evidence guide details — there is no formulation-specific trial evidence that a sublingual tablet delivers the dose an injection does. A representative ODT program runs $199 per month monthly, dropping to $165–$177 on committed plans, so an annual total of roughly $1,980–$2,388.
That annual figure looks competitive with injectable options, but the comparison is not apples-to-apples: you are paying for a route whose dose-to-effect relationship is unestablished. A lower annual price for an unproven formulation is not automatically better value than a higher price for a proven one.
The fees that inflate the real total
Beyond the medication, annual totals swell from fees that monthly ads omit: mandatory membership charges, required lab work, clinician consultation fees, shipping, onboarding fees, and dose-increase surcharges. A $99 headline plus a $40 monthly membership plus $75 in labs plus $15 shipping is not a $99 program; it is a $170 program, and $2,040 across the year.
The discipline that protects you is the effective-monthly-cost calculation: total all mandatory payments for the treatment period, divide by months supplied. Do that for every program on the same basis — our affordability methodology sets it out — and the annual comparison becomes honest. Anything hidden in tooltips or disclosed only at checkout belongs in the total.
A worked 12-month comparison
Consider four routes for a cash-pay weight-loss patient, titrating normally. Compounded injectable at a flat $150/month all-in: about $1,800 for the year. Sublingual ODT at $165/month on a 12-month plan: $1,980, for an unproven route. The Wegovy pill titrated: roughly $3,000, FDA-approved. Brand injectable Wegovy self-pay: roughly $5,000, FDA-approved, highest evidence.
Ranked by annual cost, compounded injectable wins; ranked by evidence-per-dollar, the picture shifts toward the approved products. The right choice depends on which axis matters to you — and on legality and eligibility, which are individual. What the annual view does is stop the $99-versus-$149 monthly comparison from hiding a $3,000 annual gap.
Frequently asked questions
Why is the annual cost so different from the monthly price?
Advertised monthly prices are usually the lowest possible: starter dose, first month, or a 12-month prepaid rate. The annual total reflects titration to maintenance doses, mandatory fees, and the full commitment — which the monthly headline omits.
What's the cheapest legal annual route?
For an insured patient whose plan covers weight-loss semaglutide, copay pricing (~$300/year) is cheapest. Self-pay, the Wegovy pill is the cheapest FDA-approved route; compounded injectable is lower still where lawfully available, with the legality caveats covered on this site.
Should I prepay a 12-month plan to save?
Committed plans lower the monthly rate but bind you for a year and often restrict refunds on dispensed medication. Weigh the savings against the cancellation terms, especially for a therapy you may need to adjust or stop.